Bi-allelic inactivation of TCF1 in hepatic adenomas

Nature Genetics

Volumn 32, Issue 2, 2002, Pages 312-315

  Bluteau, Olivier ^a   Jeannot, Emmanuelle ^a   Bioulac Sage, Paulette ^b,c   Marqués, Juan Martin ^a   Blanc, Jean Frédéric ^b   Bui, Hung ^d   Beaudoin, Jean Christophe ^d   Franco, Dominique ^e   Balabaud, Charles ^b   Laurent Puig, Pierre ^a   Zucman Rossi, Jessica ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL PELLEGRIN   (France)

^d FONDATION JEAN DAUSSET CEPH   (France)

^e HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; NUCLEAR FACTOR I; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ALLELISM; AMINO ACID SUBSTITUTION; ARTICLE; CELL PROLIFERATION; CHROMOSOME 12Q; CHROMOSOME DELETION; CLINICAL ARTICLE; DIMERIZATION; DNA BINDING; FEMALE; FRAMESHIFT MUTATION; GENE INACTIVATION; GENETIC ANALYSIS; GENOTYPE; GERM LINE; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER ADENOMA; LIVER CELL CARCINOMA; MALE; MALIGNANT TRANSFORMATION; MATURITY ONSET DIABETES MELLITUS; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ADENOMA; ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 12; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; FEMALE; GENETIC MARKERS; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION, MISSENSE; NUCLEAR PROTEINS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 18644363653     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1001     Document Type: Article

References (29)

1. Frain, M. et al. The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell 59, 145-157 (1989).
2. Cereghini, S., Yaniv, M. & Cortese, R. Hepatocyte dedifferentiation and extinction is accompanied by a block in the synthesis of mRNA coding for the transcription factor HNF1/LFB1. EMBO J. 9, 2257-2263 (1990).
3. Yamagata, K. et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384, 455-458 (1996).
4. Edmondson, H.A., Henderson, B. & Benton, B. Liver-cell adenomas associated with use of oral contraceptives. N. Engl. J. Med. 294, 470-472 (1976).
5. Sale, G.E. & Lerner, K.G. Multiple tumors after androgen therapy. Arch. Pathol. Lab. Med. 101, 600-603 (1977).
6. Howell, R.R., Stevenson, R.E., Ben-Menachem, Y., Phyliky, R.L. & Berry, D.H. Hepatic adenomata with type 1 glycogen storage disease. JAMA 236, 1481-1484 (1976).
7. Flejou, J.F. et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 89, 1132-1138 (1985).
8. Chiche, L. et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann. Surg. 231, 74-81 (2000).
9. Goldfarb, S. Sex hormones and hepatic neoplasia. Cancer Res. 36, 2584-2588 (1976).
10. Ferrell, L.D. Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report. Am. J. Surg. Pathol. 17, 525-529 (1993).
11. Baumhueter, S. et al. HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APF. Genes Dev. 4, 372-379 (1990).
12. Chouard, T. et al. A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. Nucleic Acids Res. 18, 5853-5863 (1990).
13. Kaisaki, P.J. et al. Mutations in the hepatocyte nuclear factor-1α gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 46, 528-535 (1997).
14. Tsukuma, H. et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 328, 1797-1801 (1993).
15. Nicosia, A. et al. A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell 61, 1225-1236 (1990).
16. Schott, O., Billeter, M., Leiting, B., Wider, G. & Wuthrich, K. The NMR solution structure of the non-classical homeodomain from the rat liver LFB1/HNF1 transcription factor. J. Mol. Biol. 267, 673-683 (1997).
17. Vaxillaire, M. et al. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J. Biol. Chem. 274, 35639-35646 (1999).
18. Ellard, S. Hepatocyte nuclear factor 1α (HNF-1α) mutations in maturity-onset diabetes of the young. Hum. Mutat. 16, 377-385 (2000).
19. Boland, C.R. et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248-5257 (1998).
20. Yamagata, K. et al. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1α is dominant negative. Diabetes 47, 1231-1235 (1998).
21. Collet, C. et al. Prevalence of the missense mutation Gly574Ser in the hepatocyte nuclear factor-1α in Africans with diabetes. Diabetes Metab. 28, 39-44 (2002).
22. Foster, J.H., Donohue, T.A. & Berman, M.M. Familial liver-cell adenomas and diabetes mellitus. N. Engl. J. Med. 299, 239-241 (1978).
23. Knudson, A.G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820-823 (1971).
24. Comings, D.E. A general theory of carcinogenesis. Proc. Natl Acad. Sci. USA 70, 3324-3328 (1973).
25. Pontoglio, M. et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84, 575-585 (1996).
26. Lee, Y.H., Sauer, B. & Gonzalez, F.J. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1α knockout mouse. Mol. Cell Biol. 18, 3059-3068 (1998).
27. Miller, S.A., Dykes, D.D. & Polesky, H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215 (1988).
28. Laurent-Puig, P. et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 120, 1763-1773 (2001).
29. Lander, E.S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).